| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 210,797 | 224,576 | 258,390 | 284,937 | | Cost of Revenue | 5,494 | 5,530 | 6,631 | 7,992 | | | Gross Profit | 205,303 | 219,046 | 251,759 | 276,945 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,135 | 91,731 | 46,387 | 50,493 | | Non Recurring | 14,767 | 24,817 | 25,331 | 149,972 | | Others | (668,585) | 459,801 | 281,788 | 275,415 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (596,306) | (357,303) | (101,747) | (198,935) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (503,194) | 221,379 | 133,877 | 317,650 | | Earnings Before Interest And Taxes | (1,527,821) | (20,683) | (101,747) | 125,172 | | Interest Expense | 113,937 | 127,186 | 131,165 | 161,153 | | Income Before Tax | (1,641,758) | (147,869) | (232,912) | (35,981) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| (78) | | | | Net Income From Continuing Ops | (238,884) | (281,746) | (99,035) | (35,981) | | | Non-recurring Events | | Discontinued Operations | (8,558) | (227) | 11,963 | 23,464 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (246,444) | (281,973) | (87,072) | (12,517) | | Preferred Stock And Other Adjustments | (12,094) | (10,309) | (9,337) | (10,580) | | | Net Income Applicable To Common Shares | ($258,538) | ($292,282) | ($96,409) | ($23,097) |
|
0.03% Nasdaq 
Income Statement
